We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+22.28%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$189M
AUM Growth
+$57.4M
Cap. Flow
+$30.2M
Cap. Flow %
15.95%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
XFOR icon
X4 Pharmaceuticals
XFOR
+$26.3M
2
ETRM
EnteroMedics Inc.
ETRM
+$4.52M

Top Sells

Rank Stock Value
1
EVAR
Lombard Medical, Inc.
EVAR
+$574K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$72.1M 38.09%
2,956,456
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$38.9M 20.55%
1,716,303
– –
KALV
3
DELISTED
KalVista Pharmaceuticals
KALV
$25.1M 13.28%
2,579,490
– –
XFOR icon
4
X4 Pharmaceuticals
XFOR
$419M
$23.8M 12.6%
+10,383
New +$26.3M
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$14.6M 7.69%
580,515
– –
OCUL icon
6
Ocular Therapeutix
OCUL
$2.38B
$7.14M 3.77%
1,605,207
– –
ATXS
7
DELISTED
Astria Therapeutics
ATXS
$4.26M 2.25%
47,628
– –
ETRM
8
DELISTED
EnteroMedics Inc.
ETRM
$3.33M 1.76%
+2,250,958
New +$4.52M
EVAR
9
DELISTED
Lombard Medical, Inc.
EVAR
– –
-1,275,779
Closed -$574K

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q4 2017 Portfolio in Review

As of Q4 2017, SV Health Investors held 9 positions worth $189M, up 44% from $132M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $30.2M of net new capital in Q4 2017, opening 2 new positions. Its largest new stake was X4 Pharmaceuticals: 10,383 shares worth $23.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Lombard Medical, Inc., an estimated $574K sold.

  • SV Health Investors's largest Q4 2017 buy was X4 Pharmaceuticals: 10,383 shares worth $23.8M.
  • SV Health Investors fully exited Lombard Medical, Inc. in Q4 2017, selling an estimated $574K.
  • SV Health Investors's ten largest holdings make up 100% of its $189M portfolio in Q4 2017.
  • SV Health Investors opened 2 new positions and closed 1 in Q4 2017.
  • SV Health Investors's portfolio value rose 44% quarter-over-quarter to $189M.

Based on SV Health Investors's 13F filing for Q4 2017, filed 14 Feb 2018.